The passage of President Trump's signature tax cut bill shows how the health care industry's influence is waning.

Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

Hype around a Microsoft AI agent's ability to diagnose difficult cases misses the mark and overlooks real innovation, experts ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

When female athletes collapse on the playing field, they are less likely to be resuscitated than men: How gender differences ...

Pervasive stigma around cannabis use is leading some ER doctors to overdiagnose a rare marijuana-related syndrome.

From my colleague Andrew Joseph: Novartis said today that Swiss regulators have approved its malaria medicine Coartem for newborns and young infants, extending a long-standing treatment to the ...

Six major medical groups, and a pregnant physician, are suing HHS Secretary Robert F. Kennedy Jr. over changes he made to ...

The steady erosion of experienced staff is slowly compromising FDA work and low morale is pushing more workers to the exits ...

WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...

Survival rates in cancer patients on immune checkpoint inhibitors depended on their insurance coverage, new study found.